Potential pathophysiological mechanism of cancer-related fatigue and current management

Chi-Tai Yeh, Liang Shun Wang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cancer-related fatigue (CRF) is a common and crucial disease entity encountered by oncologists, which has been well defined in the International Classification of Diseases (10th Revision). However, CRF is under recognized and difficult to treat. Cancer-related fatigue is frequently associated with advance-staged tumors and cancer therapies such as surgery, chemotherapy, and radiotherapy. Several studies have evaluated the use of drug interventions in CRF management but have conflicting results, depending on the population studied and the outcome measures used. Cancer-related fatigue is apparently associated with systemic inflammation that involves chronic activation/deregulation of the immune system. Traditional Chinese medicine (TCM) approaches may modulate immune functions. Botanical supplements are used worldwide to enhance immune responses and reduce pathogen-associated symptoms. This minireview includes an assessment of the efficacy of drug treatment in managing CRF, and a translational investigation of the anti-CRF activity of TCMs and their isolated components. In addition, we explored the possible mechanisms of action underlying TCM-mediated effects and their roles in immunomodulation. Furthermore, TCMs have demonstrated a spectrum of activities. For instance, TCMs inhibit cyclooxygenase and nitric oxide synthesis, promote free radical scavenging activity, and reduce inflammatory cytokines. In addition, evidence supports that TCMs restore impaired T cell functions, improve the M1/M2 macrophage ratio and cytokine balance, inhibit CD4+CD25+ regulatory T (Treg) cells, and suppress chemoradio-resistance in patients with cancer, which suggest TCMs are promising candidates for the development of new drug therapies against CRF.

Original languageEnglish
Pages (from-to)173-182
Number of pages10
JournalFormosan Journal of Surgery
Volume47
Issue number5
DOIs
Publication statusPublished - Oct 1 2014

Fingerprint

Fatigue
Neoplasms
Chinese Traditional Medicine
Regulatory T-Lymphocytes
Cytokines
Drug Therapy
Immunomodulation
International Classification of Diseases
Prostaglandin-Endoperoxide Synthases
Pharmaceutical Preparations
Free Radicals
Immune System
Nitric Oxide
Radiotherapy
Macrophages
Outcome Assessment (Health Care)
Inflammation
T-Lymphocytes

Keywords

  • Astragalus polysaccharide
  • Cancer-related fatigue
  • Chronic inflammation
  • Immunomodulator
  • Traditional Chinese medicine

ASJC Scopus subject areas

  • Surgery

Cite this

Potential pathophysiological mechanism of cancer-related fatigue and current management. / Yeh, Chi-Tai; Wang, Liang Shun.

In: Formosan Journal of Surgery, Vol. 47, No. 5, 01.10.2014, p. 173-182.

Research output: Contribution to journalArticle

Yeh, Chi-Tai ; Wang, Liang Shun. / Potential pathophysiological mechanism of cancer-related fatigue and current management. In: Formosan Journal of Surgery. 2014 ; Vol. 47, No. 5. pp. 173-182.
@article{aba8f226bb40402c95eb77e423683867,
title = "Potential pathophysiological mechanism of cancer-related fatigue and current management",
abstract = "Cancer-related fatigue (CRF) is a common and crucial disease entity encountered by oncologists, which has been well defined in the International Classification of Diseases (10th Revision). However, CRF is under recognized and difficult to treat. Cancer-related fatigue is frequently associated with advance-staged tumors and cancer therapies such as surgery, chemotherapy, and radiotherapy. Several studies have evaluated the use of drug interventions in CRF management but have conflicting results, depending on the population studied and the outcome measures used. Cancer-related fatigue is apparently associated with systemic inflammation that involves chronic activation/deregulation of the immune system. Traditional Chinese medicine (TCM) approaches may modulate immune functions. Botanical supplements are used worldwide to enhance immune responses and reduce pathogen-associated symptoms. This minireview includes an assessment of the efficacy of drug treatment in managing CRF, and a translational investigation of the anti-CRF activity of TCMs and their isolated components. In addition, we explored the possible mechanisms of action underlying TCM-mediated effects and their roles in immunomodulation. Furthermore, TCMs have demonstrated a spectrum of activities. For instance, TCMs inhibit cyclooxygenase and nitric oxide synthesis, promote free radical scavenging activity, and reduce inflammatory cytokines. In addition, evidence supports that TCMs restore impaired T cell functions, improve the M1/M2 macrophage ratio and cytokine balance, inhibit CD4+CD25+ regulatory T (Treg) cells, and suppress chemoradio-resistance in patients with cancer, which suggest TCMs are promising candidates for the development of new drug therapies against CRF.",
keywords = "Astragalus polysaccharide, Cancer-related fatigue, Chronic inflammation, Immunomodulator, Traditional Chinese medicine",
author = "Chi-Tai Yeh and Wang, {Liang Shun}",
year = "2014",
month = "10",
day = "1",
doi = "10.1016/j.fjs.2014.09.001",
language = "English",
volume = "47",
pages = "173--182",
journal = "Formosan Journal of Surgery",
issn = "1011-6788",
publisher = "臺灣外科醫學會",
number = "5",

}

TY - JOUR

T1 - Potential pathophysiological mechanism of cancer-related fatigue and current management

AU - Yeh, Chi-Tai

AU - Wang, Liang Shun

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Cancer-related fatigue (CRF) is a common and crucial disease entity encountered by oncologists, which has been well defined in the International Classification of Diseases (10th Revision). However, CRF is under recognized and difficult to treat. Cancer-related fatigue is frequently associated with advance-staged tumors and cancer therapies such as surgery, chemotherapy, and radiotherapy. Several studies have evaluated the use of drug interventions in CRF management but have conflicting results, depending on the population studied and the outcome measures used. Cancer-related fatigue is apparently associated with systemic inflammation that involves chronic activation/deregulation of the immune system. Traditional Chinese medicine (TCM) approaches may modulate immune functions. Botanical supplements are used worldwide to enhance immune responses and reduce pathogen-associated symptoms. This minireview includes an assessment of the efficacy of drug treatment in managing CRF, and a translational investigation of the anti-CRF activity of TCMs and their isolated components. In addition, we explored the possible mechanisms of action underlying TCM-mediated effects and their roles in immunomodulation. Furthermore, TCMs have demonstrated a spectrum of activities. For instance, TCMs inhibit cyclooxygenase and nitric oxide synthesis, promote free radical scavenging activity, and reduce inflammatory cytokines. In addition, evidence supports that TCMs restore impaired T cell functions, improve the M1/M2 macrophage ratio and cytokine balance, inhibit CD4+CD25+ regulatory T (Treg) cells, and suppress chemoradio-resistance in patients with cancer, which suggest TCMs are promising candidates for the development of new drug therapies against CRF.

AB - Cancer-related fatigue (CRF) is a common and crucial disease entity encountered by oncologists, which has been well defined in the International Classification of Diseases (10th Revision). However, CRF is under recognized and difficult to treat. Cancer-related fatigue is frequently associated with advance-staged tumors and cancer therapies such as surgery, chemotherapy, and radiotherapy. Several studies have evaluated the use of drug interventions in CRF management but have conflicting results, depending on the population studied and the outcome measures used. Cancer-related fatigue is apparently associated with systemic inflammation that involves chronic activation/deregulation of the immune system. Traditional Chinese medicine (TCM) approaches may modulate immune functions. Botanical supplements are used worldwide to enhance immune responses and reduce pathogen-associated symptoms. This minireview includes an assessment of the efficacy of drug treatment in managing CRF, and a translational investigation of the anti-CRF activity of TCMs and their isolated components. In addition, we explored the possible mechanisms of action underlying TCM-mediated effects and their roles in immunomodulation. Furthermore, TCMs have demonstrated a spectrum of activities. For instance, TCMs inhibit cyclooxygenase and nitric oxide synthesis, promote free radical scavenging activity, and reduce inflammatory cytokines. In addition, evidence supports that TCMs restore impaired T cell functions, improve the M1/M2 macrophage ratio and cytokine balance, inhibit CD4+CD25+ regulatory T (Treg) cells, and suppress chemoradio-resistance in patients with cancer, which suggest TCMs are promising candidates for the development of new drug therapies against CRF.

KW - Astragalus polysaccharide

KW - Cancer-related fatigue

KW - Chronic inflammation

KW - Immunomodulator

KW - Traditional Chinese medicine

UR - http://www.scopus.com/inward/record.url?scp=84919441684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919441684&partnerID=8YFLogxK

U2 - 10.1016/j.fjs.2014.09.001

DO - 10.1016/j.fjs.2014.09.001

M3 - Article

AN - SCOPUS:84919441684

VL - 47

SP - 173

EP - 182

JO - Formosan Journal of Surgery

JF - Formosan Journal of Surgery

SN - 1011-6788

IS - 5

ER -